Vilin Bio Med Limited is an India-based company engaged in the business of manufacturing and selling pharmaceutical products. The Company is engaged in the manufacturing of pharmaceutical formulations, such as oral liquids, dry syrups, sachets, external preparations, beta and non-beta lactam tablets and capsules and nutritional food supplements. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotic drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system and anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals and amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) tablets, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, ciprofloxacin, fluocinolone acetonide and others.As of 25 Jun 2026, VILIN BIO MED LIMITED share price is ₹43.70. The stock opened at ₹46.00, compared to its previous close of ₹46.00. During today's trading session, VILIN BIO MED LIMITED share price moved in the range of ₹43.70 to ₹46.00, with an average price of ₹44.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹43.70 and a high of ₹46.00. On the performance front, VILIN BIO MED LIMITED share price has increased by 117.96% over the last six months and is up 56.91% on a year-on-year basis.
The market capitalization of VILIN BIO MED LIMITED is ₹70 Crs and a dividend yield of 0.00%.